Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Erin Kyle
CIBC

Erin Kyle

CIBC
Wall Street Analyst
★★★☆☆
#1209
on 13Foresight · ranked by our own returns
55%
Success Rate
+2.5%
Average Return
22 of 40 calls profitable · -185.5% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 55% of Erin Kyle's ratings turned a profit when each position was held for 1 year — averaging +2.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

43 Buy 19 Hold 0 Sell
Erin's Stock Coverage 13 ratings · 2026-11-13
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
TSE:DHT.UN
DRI Healthcare
 Oct 30, 2026 BUY Strong Buy
+19.9% avg upside
8 analysts
$21.50
18.53% Upside
 +6.0% ·
TSE:CIGI
Colliers International Group
 Oct 30, 2026 BUY Strong Buy
+42.9% avg upside
16 analysts
$181.68
34.26% Upside
 -1.0% ·
TSE:TSAT
Telesat Corp
 Oct 30, 2026 BUY Buy
+65.5% avg upside
6 analysts
$105.00
88.00% Upside
 +5.5% ·
TSE:FSV
FirstService
 Oct 23, 2026 BUY Strong Buy
+20.7% avg upside
15 analysts
$248.76
23.08% Upside
 +7.5% ·
TSE:DND
Dye & Durham
 Oct 14, 2026 HOLD Buy
+575.9% avg upside
7 analysts
$2.00
35.97% Upside
 -11.5% ·
TSE:DTOL
D2L
 Sep 10, 2026 HOLD Strong Buy
+28.2% avg upside
7 analysts
$11.00
2.27% Upside
 +16.1% ·
TSE:APTX
Apotex Health Corp.
 Aug 13, 2026 BUY Strong Buy
+21.9% avg upside
12 analysts
$40.00
19.79% Upside
 +1.1% ·
TSE:CMG
Computer Modelling
 Aug 13, 2026 HOLD Hold
+101.3% avg upside
10 analysts
$5.00
24.75% Upside
 -1.0% ·
TSE:MDA
MDA Space Ltd
 Aug 10, 2026 BUY Strong Buy
+65.1% avg upside
18 analysts
$59.00
55.35% Upside
 -13.9% ·
TSE:DCBO
Docebo
 Aug 10, 2026 BUY Strong Buy
+14.7% avg upside
16 analysts
$41.23
0.82% Downside
 +26.4% ·
TSE:AIF
Altus Group
Jul 20, 2026 HOLD Buy
+10.7% avg upside
10 analysts
$53.00
5.20% Upside
 +11.4% ·
TSE:ENGH
Enghouse Systems
 Jun 11, 2026 HOLD Hold
+81.5% avg upside
6 analysts
$17.00
7.04% Downside
 +14.9% ·
TSE:WELL
WELL Health Technologies Corp
 Jun 03, 2026 BUY Strong Buy
+65.5% avg upside
11 analysts
$6.00
43.56% Upside
 -13.9% ·
🔒 8 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Erin Kyle — Frequently Asked Questions
How accurate are Erin Kyle's stock ratings?
Based on the calls 13Foresight could measure, about 55% of Erin's ratings were profitable over a one-year hold, with an average return of +2.5% per rating, or +25.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Erin ranked on 13Foresight?
Erin Kyle is currently ranked #1209 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Erin cover?
Erin most recently has ratings on TSE:DHT.UN, TSE:CIGI, TSE:TSAT, TSE:FSV, TSE:DND, TSE:DTOL, TSE:APTX, TSE:CMG, TSE:MDA, TSE:DCBO, TSE:AIF, TSE:ENGH and 1 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.